Screener
Arrowhead Research
ARWRArrowhead Pharmaceuticals is a commercial-stage biotechnology company specializing in medicines that treat intractable diseases by silencing causative genes.
Earnings
Next report
Nov 24, 2026 (In 3 weeks)Revenue estimate$61.2M
EPS estimate-$1.52
Valuation & ratios
Competitors
By market cap
By revenue growth
Profile
Arrowhead Pharmaceuticals is a commercial-stage biotechnology company specializing in medicines that treat intractable diseases by silencing causative genes. The company utilizes a proprietary portfolio of RNA chemistries and delivery mechanisms to trigger RNA interference (RNAi), inducing deep and durable knockdown of target genes across a diverse clinical pipeline.
Competitive position
Arrowhead is a leader in the RNAi space, having transitioned from a R&D-focused entity to a commercial-stage organization with a robust pipeline of 18 clinical candidates.
GeographiesUnited States, Global
Customer segmentsRare disease patients, Healthcare providers, Global pharmaceutical companies
Business modelProduct-based, IP Licensing, Research and Development
SuppliersRaw material suppliers for RNA synthesis, Contract Research Organizations (CROs), Specialized laboratory equipment providers
CustomersSpecialty drug distributors, Health insurance payers, Medical institutions
CountryUnited States of America
Listed1995
Employees525.0
CEOChristopher R. Anzalone
SectorHealthcare
IndustryBiotechnology
Websitearrowheadpharma.com
FilingsSEC EDGAR
FAQ
- What is Arrowhead Research's market cap?
- Arrowhead Research (ARWR) has a market capitalization of $8.5B and trades on NASDAQ.
- What is Arrowhead Research's revenue and profitability?
- Arrowhead Research generated $669.5M in trailing twelve-month revenue with a net loss of $320.0M, representing a net margin of -47.8%, with free cash flow of -$75.1M. The latest reported period is Q3 2026.
- Who are Arrowhead Research's competitors?
- Arrowhead Research's key competitors include Alnylam Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Ultragenyx Pharmaceutical Inc., and others. These companies compete in similar markets and product categories.
- Who does Arrowhead Research partner with?
- Arrowhead Research's notable partners include Sarepta Therapeutics, Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, and others.
- Where is Arrowhead Research headquartered?
- Arrowhead Research is headquartered in United States of America and employs approximately 525 people. It has been publicly traded since 1995.
